Cybin (HELP) Research & Development (2020 - 2026)
Cybin (HELP) posted Research & Development of $28.9 million for Q1 2026, up 21.08% on a QoQ basis from $23.9 million in Q4 2025, and down 24.47% year-over-year from $38.2 million in Q1 2025.
Cybin (HELP) Research & Development (2020 - 2026) Analysis & Trends
Cybin's Research & Development history runs 7 years deep, the most recent figure standing at $28.9 million for Q1 2026.
- Quarterly Research & Development fell 24.47% year-over-year to $28.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.6 million (up 48.35% YoY) and the FY2026 annual result came in at $86.6 million, up 120.83% from the prior year.
- Research & Development was $28.9 million for Q1 2026 at Cybin, up from $23.9 million in the prior quarter.
- Across five years, Research & Development topped out at $38.2 million in Q1 2025 and bottomed at -$278040.9 in Q1 2023.
- A 5-year average of $10.3 million and a median of $4.8 million in 2023 frame the typical range for Research & Development.
- Peak annual rise in Research & Development reached 245772.7% in 2024, while the deepest fall reached 99.83% in 2024.
- Cybin's Research & Development stood at $6256.0 in 2022, then dropped by 12.66% to $5464.2 in 2023, then jumped by 245772.7% to $13.4 million in 2024, then soared by 77.57% to $23.9 million in 2025, then gained by 21.08% to $28.9 million in 2026.
- Business Quant data shows HELP's Research & Development at $28.9 million in Q1 2026, $23.9 million in Q4 2025, and $18.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Cybin | 262.76 Mn | 262.76 Mn | - | 28.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.89 Mn |
| Dec 31, 2025 | 23.86 Mn |
| Sep 30, 2025 | 18.85 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Mar 31, 2025 | 38.24 Mn |
| Dec 31, 2024 | 13.44 Mn |
| Sep 30, 2024 | 6.68 Mn |
| Jun 30, 2024 | 8,041.00 |
| Mar 31, 2024 | 24.00 Mn |
| Dec 31, 2023 | 5,464.21 |
| Sep 30, 2023 | 4,994.75 |
| Jun 30, 2023 | 4.75 Mn |
| Feb 28, 2023 | -278,040.91 |
| Dec 31, 2022 | 6,256.00 |
| Sep 30, 2022 | 5,141.00 |
| May 31, 2022 | 1.64 Mn |
| Mar 31, 2022 | 5,829.00 |
| Dec 31, 2021 | 4,963.00 |
| Sep 30, 2021 | 3.03 Mn |
| Jun 30, 2021 | 2,421.06 |